Successful treatment of severe orthostatic hypotension with erythropoietin

PACE - Pacing and Clinical Electrophysiology

Volumn 26, Issue 1 I, 2003, Pages 105-107

  Kawakami, Kazunobu ^a   Abe, Haruhiko ^a   Harayama, Nobuya ^a   Nakashima, Yasuhide ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Erythropoietin; Head up tilt test; Orthostatic hypotension; Syncope

Indexed keywords

FLUDROCORTISONE; MIDODRINE; RECOMBINANT ERYTHROPOIETIN;

AGED; ANEMIA; ARTICLE; BLOOD PRESSURE; BODY POSITION; CASE REPORT; DISEASE SEVERITY; GERIATRIC PATIENT; HUMAN; HYPOTENSION; MALE; ORTHOSTATIC HYPOTENSION; SYMPTOMATOLOGY; SYNCOPE; TREATMENT OUTCOME;

EID: 0037250299     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2003.00158.x     Document Type: Article

References (14)

1. Ando Y, Asahara K, Obayashi K, et al. Autonomic dysfunction and anemia in neurologic disorders. J Auton Nerv Syst 1996; 61:145-148.
2. Biaggioni I, Robertson D, Kranz S, et al. The anemia of primary autonomic failure and its reversal with recombinant erythropoietin. Ann Intern Med 1994; 121:181-186.
3. Hoeldtke RD, Streen DH, Phil D. Treatment of orthostatic hypotension with erythropoietin. N Engl J Med 1993; 329:611-615.
4. Perera R, Isora L, Kaufmann H. Effect of recombinant erythropoietin on anemia and orthostatic hypotension in primary autonomic failure. Clin Auton Res 1995; 5:211-214.
5. Nair B, Leitch J, Black A. Erythropoietin treatment for postual hypotension from autonomic dysfunction. Aust N J Med 1996; 26:859-860.
6. Baskin S, Lasker N. Erythropoietin-associated hypertension. N Engl J Med 1990; 323:999-1000.
7. Martin W, Smith JA, White DG. The mechanisms by which hemoglobin inhibits the relaxation of rabbit aorta induced by nitro vasodilators, nitric oxide, or bovine retractor penis inhibitory factor. Br J Pharmacol 1986; 89:563-571.
8. Raine AE. Hypertension, blood viscosity, and cardiovascular morbidity in renal failure: Implications of erythropoietin therapy. Lancet 1988; 16:97-99.
9. Neeff MS, Kim KE, Persoff M, et al. Hemodynamics of uremic anemia. Circulation 1971; 43:876-883.
10. Grubb BP, Lachant NA, Kosinski D. Erythropoietin as therapy for severe refractory orthostatic hypotension. Clin Auton Res 1994; 9:212.
11. Heidenreich S, Rahn KH, Zidek W. Direct vasopressor effect of recombinant erythropoietin on renal resistance vessels. Kidney Int 1991; 39:259-265.
12. Neusser M, Tepel M, Zidek W. Erythropoietin increases cytosolic free calcium concentration in vascular smooth muscle cells. Cardiovasc Res 1993; 27:1233-1236.
13. Takahashi K, Totsune K, Imai Y, et al. Plasma concentrations of immunoreactive-endothelin in patients with chronic renal failure treated with recombinant human erythropoietin. Clin Sci 1993; 84:47-50.
14. Jandeleit K, Heintz B, Gross-Heitleld E, et al. Increased activity of the autonomic nervous system and increased sensitivity to angiotensin II infusion after therapy with recombinant human erythropoietin. Nephron 1990; 56:220-221.